P2-CRC-D0918Active studySynthetic mock data
Yuki Tanaka — D0918-CRC-031
Stage III CRC s/p resection, ctDNA+ · Arm A · enrolled 2025-10-12
Subject ID
s-0918-031
MRN
MRN 6025331
Age / sex
52 / F
ECOG
0
Best response
CR
Σ Δ at Wk 32
—
RECIST 1.1 — Target lesions
Serial measurements (mm) and per-visit response
Sum-of-diameters; % from baseline (PR ≤ -30%); % from nadir (PD ≥ +20% absolute ≥ 5 mm)
| Lesion | Modality | Baseline2025-09-04 | Wk 82025-10-30 | Wk 162025-12-25 | Wk 242026-02-19 | Wk 322026-04-16 |
|---|---|---|---|---|---|---|
| Sum of diameters | mm | — | — | — | — | — |
| % from baseline | — | — | — | — | — | |
| % from nadir | — | — | — | — | — | |
| RECIST response | NE | CR | CR | CR | CR |
Non-target lesions
Per-visit qualitative status (presence / absence / equivocal / new)
| Lesion | Baseline | Wk 8 | Wk 16 | Wk 24 | Wk 32 |
|---|---|---|---|---|---|
| Surgical bed | absent | absent | absent | absent | absent |
Other subjects in P2-CRC-D0918
s-0918-007
Sara Khan
Arm A · PR
s-0918-014
Henry Park
Arm A · CR
s-0918-031
Yuki Tanaka
Arm A · CR
s-0918-040
Omar Hassan
Arm B · SD
s-0918-052
Priya Singh
Arm B · SD
23 subjects across all studies in workspace.